These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26681526)

  • 1. Estrogen action: Receptors, transcripts, cell signaling, and non-coding RNAs in normal physiology and disease.
    Klinge CM
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():191-2. PubMed ID: 26681526
    [No Abstract]   [Full Text] [Related]  

  • 2. The gene regulatory networks controlled by estrogens.
    Gao H; Dahlman-Wright K
    Mol Cell Endocrinol; 2011 Mar; 334(1-2):83-90. PubMed ID: 20837099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen carcinogenesis in breast cancer.
    Germain D
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):473-84, vii. PubMed ID: 21889715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen-dependent regulation of miRNA biogenesis: many ways to skin the cat.
    Gupta A; Caffrey E; Callagy G; Gupta S
    Biochem Soc Trans; 2012 Aug; 40(4):752-8. PubMed ID: 22817728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.
    Nagpal N; Ahmad HM; Molparia B; Kulshreshtha R
    Carcinogenesis; 2013 Aug; 34(8):1889-99. PubMed ID: 23542418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [I. Predict factor for hormone sensitivity and resistance].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2500-4. PubMed ID: 24422236
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogen-estrogen receptor signaling suppresses the transcription of ERRF in breast cancer cells.
    Luo A; Su D; Zhang X; Qi L; Fu L; Dong JT
    J Genet Genomics; 2016 Sep; 43(9):565-567. PubMed ID: 27599921
    [No Abstract]   [Full Text] [Related]  

  • 8. Crosstalk between Estrogen Signaling and Breast Cancer Metabolism.
    Kulkoyluoglu-Cotul E; Arca A; Madak-Erdogan Z
    Trends Endocrinol Metab; 2019 Jan; 30(1):25-38. PubMed ID: 30471920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
    Hossain A; Kuo MT; Saunders GF
    Mol Cell Biol; 2006 Nov; 26(21):8191-201. PubMed ID: 16940181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.
    Kim JW; Akiyama M; Park JH; Lin ML; Shimo A; Ueki T; Daigo Y; Tsunoda T; Nishidate T; Nakamura Y; Katagiri T
    Cancer Sci; 2009 Aug; 100(8):1468-78. PubMed ID: 19496786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA as a New Regulatory Mechanism of Estrogen Vascular Action.
    Pérez-Cremades D; Mompeón A; Vidal-Gómez X; Hermenegildo C; Novella S
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptors and cell signaling.
    Pietras RJ; Levin ER; Szego CM
    Science; 2005 Oct; 310(5745):51-3; author reply 51-3. PubMed ID: 16210518
    [No Abstract]   [Full Text] [Related]  

  • 13. Membrane-initiated steroid signaling action of estrogen and breast cancer.
    Song RX
    Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen signalling and steroid receptor crosstalk in endocrine cancers.
    Claessens F; Tilley W
    Endocr Relat Cancer; 2014 Aug; 21(4):E3-5. PubMed ID: 25052914
    [No Abstract]   [Full Text] [Related]  

  • 15. Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer.
    Ijichi N; Shigekawa T; Ikeda K; Horie-Inoue K; Fujimura T; Tsuda H; Osaki A; Saeki T; Inoue S
    J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):1-7. PubMed ID: 20883782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy.
    Nicholson RI; Staka C; Boyns F; Hutcheson IR; Gee JM
    Endocr Relat Cancer; 2004 Dec; 11(4):623-41. PubMed ID: 15613443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual roles of estrogen metabolism in mammary carcinogenesis.
    Chang M
    BMB Rep; 2011 Jul; 44(7):423-34. PubMed ID: 21777512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein arginine methylation in estrogen signaling and estrogen-related cancers.
    Teyssier C; Le Romancer M; Sentis S; Jalaguier S; Corbo L; Cavaillès V
    Trends Endocrinol Metab; 2010 Mar; 21(3):181-9. PubMed ID: 20005732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining estrogen regulation of cancer stem cells through multicolor lineage tracing.
    Zhang Y; Eades G; Zhou Q
    Methods Mol Biol; 2014; 1204():35-44. PubMed ID: 25182759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.